75706-12-6 Leflunomide AKSci H527
 
 
Loading Please Wait...
  H527    
Leflunomide, 98% (HPLC)
 
5-Methylisoxazole-4-(4-trifluoromethylcarboxanilide)
IDENTITY
CAS Number:75706-12-6
MDL Number:MFCD00867593
MF:C12H9F3N2O2
MW:270.21
BRN:4323174
SPECIFICATIONS & PROPERTIES
Min. Purity Spec:98% (HPLC)
Spectra:NMR, HPLC
Physical Form (at 20°C):White or almost white crystalline powder
Melting Point:164-170°C
Density:1.392
Refractive Index:1.541
Long-Term Storage:Store long-term at 2-8°C
DOT/IATA TRANSPORT INFORMATION
UN #:UN2811
Hazard Class:6.1; Poison
Packing Group:III
A hazmat fee may apply, depending on the amount ordered.

BIOLOGICAL INFO
Application(s):An inhibitor of Cox-2 and tyrosine kinase

REVIEW
 Leflunomide is an immunosuppressive drug that inhibits T and B cell responses. Leflunomide is an inhibitor of Cox-2, of tyrosine phosphorylation (tyrosine kinase), of DHODH (dihydroorotate dehydrogenase), an enzyme for de novo pyrimidine synthesis, and of TNF-dependent NF-κB activation. The physiological activity of leflunomide is attributed mainly to its metabolite.

REFERENCES
[1]Bartlett, R.R., et al. 1985. Int. J. Immunopharmacol. 7: 7-18. PMID: 3873420
[2] Bartlett, R.R., et al. 1991. Agents Actions 32: 10-21. PMID: 2058454
[3] Mattar, T., et al. 1993. FEBS Lett. 334: 161-164. PMID: 8224241
[4] Xu, X., et al. 1995. J. Biol. Chem. 270: 12398-12403. PMID: 7759480

GLOBALLY HARMONIZED SYSTEM (GHS)

Pictograms

Signal Word
Danger

Hazard Statements
H301; H315; H319; H335

Precautionary Statements
P261; P264; P270; P271; P280; P301+P310; P302+P352; P304+P340; P305+P351+P338; P312; P321; P330; P332+P313; P337+P313; P362; P403+P233; P405; P501

Current as of January 25, 2022


Download SDS

For research use only. Not for diagnostic or therapeutic use. Not for human use. AK Scientific, Inc. does not sell to individuals. If you are a first-time customer, please email for review at least two official business documents issued by your local jurisdiction, state/province, or country.


CATEGORIES
 APIs and Bioactives > Pyrimidine Synthesis Inhibitors


PubChem